InsidersTradesSigma
Roivant Sciences Ltd.: management transactions · United States · SEC (Form 4)
SEC:roivant-sciences-ltd-a473e9US·SEC (Form 4)Mcap 20.4Bn€Healthcare
Browse the full directors' dealings record of Roivant Sciences Ltd., a listed issuer based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Healthcare sector, Roivant Sciences Ltd. has recorded 17 public disclosures. Market capitalisation: €20.4bn. The latest transaction was disclosed on 24 May 2022 — Cession. Among the most active insiders: Kumar Rakhi. Every trade is openly available.
17
Insider Decl.
0
Thresholds
€111,967
1 ops.
Buy Volume
€3m
16 ops.
Sell Volume
Financial data
FY ended March 2025 · cache
28.45 €
Analyst consensus
12 analystsStrong buy
29.50 €Target 35.71 €(+25%)41.00 €
Income statement
Revenue29.1 M€
Gross profit28.1 M€97% margin
Net income−172.0 M€-592.0% margin
Valuation
PER (forward)-24.6x
P/Book4.7x
Beta1.14
Balance sheet & cash
Market cap20.37 Bn€
Total debt100.2 M€
Free Cash Flow−844.0 M€
Debt / Equity2%
Profitability & ownership
ROE-19.1%
ROA-14.5%
% insiders22.8%
% institutions78.0%
Last declaration on 24 May 2022
Declarations0 total
No declarations found
0 of 0 declarations